Growth Metrics

Nutex Health (NUTX) Depreciation and Depletion (2016 - 2022)

Nutex Health (NUTX) has disclosed Depreciation and Depletion for 13 consecutive years, with $1564.0 as the latest value for Q1 2022.

  • For Q1 2022, Depreciation and Depletion rose 48.39% year-over-year to $1564.0; the TTM value through Mar 2022 reached $5158.0, down 50.72%, while the annual FY2021 figure was $4648.0, 67.98% down from the prior year.
  • Depreciation and Depletion hit $1564.0 in Q1 2022 for Nutex Health, down from $1656.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $16264.0 in Q1 2019 and bottomed at -$10908.0 in Q2 2019.
  • Average Depreciation and Depletion over 5 years is $2174.8, with a median of $1054.0 recorded in 2021.
  • On a YoY basis, Depreciation and Depletion climbed as much as 3664.81% in 2019 and fell as far as 2630.86% in 2019.
  • Nutex Health's Depreciation and Depletion stood at -$773.0 in 2018, then skyrocketed by 1321.86% to $9445.0 in 2019, then plummeted by 87.95% to $1138.0 in 2020, then surged by 45.52% to $1656.0 in 2021, then fell by 5.56% to $1564.0 in 2022.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $1564.0, $1656.0, and $968.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.